Vera’s phase 2b ORIGIN data was underwhelming with lower than expected proteinuria reduction ~31% even at 9 months. We believe Atacicept’s commercial opportunity in IgAN is questionable due to the ...
And that may be part of the allure for Big Tech companies looking to the heavens for their data center solutions. Jeff Bezos’ Blue Origin and Elon Musk’s SpaceX are working on plans to launch orbital ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback